IP Licensing & Contracts

Intangible Assets


Increasingly, businesses are both licensors and licensees of technologies.  Our intellectual property attorneys draft and negotiate license agreements for computer hardware, software, maintenance, data, computer systems, and networks, as well as for telecommunications services, business methods, data processing, information technology services, data storage, outsourcing, joint development, and disaster recovery and business continuity.  We have represented both licensors and licensees in domestic and international transactions.  Our work on behalf of clients involves joint ventures and joint development agreements, patent, copyright and trademark licenses, and protection of proprietary “know-how.”

Blank Rome attorneys help companies grow and raise capital through technology transfer transactions, including technology development agreements; patent and technology licenses; CRADAs; MTAs and sponsored research agreements; codevelopment and joint marketing agreements; and manufacturing agreements.

Select Engagements

  • Biopharmaceutical company in all worldwide licensing of 100% fucose-free monoclonal antibodies proven to significantly enhance the ability of antibodies to kill tumor cells.
  • Patent and licensing matters in the United States and internationally for a leading Japanese manufacturer of drugs and diagnostic reagents, including amino and nucleic acids for pharmaceutical and industrial use, bulk pharmaceuticals, animal health products, agrochemicals, health foods, and raw material alcohol. 
  • Electronic stock market in negotiations of a joint development/operating agreement with a major mutual fund company to bring a family of innovative financial products to market.  The transaction also involved trademark licenses and joint marketing arrangements.
  • Counseled a B2B and B2C home-and-garden retailer in all aspects of establishing and operating an online marketplace providing individual and corporate buyers of home and garden products a single online venue to conduct sales transactions.
  • Nonprofit infectious-disease research institute and patent holder in a transaction to securitize the royalty stream from an innovative biotechnology patent.  The transaction involved patent due diligence, tax, and secured financing matters.